Senzar Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Senzar Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-11,123	Closed	-$485K	–	21
2018 Q2	$485K	Sell	11,123 -116,441	-91%	-$5M	1.4%	19
2018 Q1	$5.04M	Buy	+127,564	New	+$4.96M	1.59%	25
2017 Q2	–	Sell	-195,289	Closed	-$2.85M	–	32
2017 Q1	$2.85M	Buy	195,289 +7,540	+4%	+$112K	0.72%	25
2016 Q4	$2.67M	Buy	187,749 +23,960	+15%	+$371K	0.71%	24
2016 Q3	$2.87M	Sell	163,789 -23,430	-13%	-$389K	0.74%	33
2016 Q2	$3.2M	Sell	187,219 -20,390	-10%	-$365K	0.7%	34
2016 Q1	$4.09M	Buy	207,609 +13,200	+7%	+$212K	0.81%	28
2015 Q4	$3.69M	Buy	194,409 +17,710	+10%	+$361K	0.41%	37
2015 Q3	$3.37M	Buy	+176,699	New	+$6M	0.49%	30

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Senzar Asset Management's ARNA Position: Q3 2018 in Review

Senzar Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2018, closing a stake of 11,123 shares — an estimated $485K sold.

Senzar Asset Management first reported a position in ARNA in Q3 2015 and held it in 9 quarters. The position peaked at $5.04M in Q1 2018. 160 funds tracked by Wall St. Rank hold ARNA as of Q3 2018.

Senzar Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
Senzar Asset Management sold 11,123 Arena Pharmaceuticals Inc shares in Q3 2018, an estimated $485K.
Senzar Asset Management first reported a position in Arena Pharmaceuticals Inc in Q3 2015 and held it in 9 quarters.
Senzar Asset Management's Arena Pharmaceuticals Inc position peaked at $5.04M in Q1 2018.
160 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2018.

Based on Senzar Asset Management's 13F filing for Q3 2018.